Connect your AI

BBNX BBNX Investment Purchases

Investment Purchases at other companies

Tandem Diabetes CareTNDM

$216.13M+2,187%

MedtronicMDT

$2.15B+0.9%

Halozyme TherapeuticsHALO

$8.85M-93.7%

Other financials

Income statement

Revenue$27.6M+56.6%

Gross profit$16.4M+83.2%

Operating income-$24.3M-30.2%

Net income-$21.9M+23.6%

EPS (diluted)-$0.49+47.3%

Balance sheet

Cash & equivalents$30.2M-28.9%

Total debt$6.9M-0.9%

Total equity$271.2M-13.5%

Total assets$304.4M-9.9%

Cash flow

Operating cash flow-$23.8M-19.3%

CapEx$1.4M+314%

Free cash flow-$25.2M-24.1%

Valuation

Market cap$708.98M-8.6%

Enterprise value$685.68M—

P/S6.4×—

Profitability

Gross margin57.2%+3.2pp

Operating margin-70.1%-6.4pp

Net margin-60.3%-17.4pp

FCF margin-55.4%-14.3pp

Returns & leverage

Return on equity-22.7%—

Debt / equity0×0.0×

Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.

The official record: BBNX’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is BBNX's investment purchases?: BBNX (BBNX) reported investment purchases of $45.26M in Q4 2025.
How has BBNX's investment purchases changed year-over-year?: BBNX's investment purchases increased by 0.4% year-over-year, from $45.1M to $45.26M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.